ST ELEVATIONS DURING LEFT ATRIAL APPENDAGE OCCLUSION (LAAO) SECONDARY TO WATCHMAN DEVICE COMPRESSION OF THE LEFT CIRCUMFLEX (LCX) ARTERY: A CASE REPORT

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
{"title":"ST ELEVATIONS DURING LEFT ATRIAL APPENDAGE OCCLUSION (LAAO) SECONDARY TO WATCHMAN DEVICE COMPRESSION OF THE LEFT CIRCUMFLEX (LCX) ARTERY: A CASE REPORT","authors":"","doi":"10.1016/j.ajpc.2024.100799","DOIUrl":null,"url":null,"abstract":"<div><h3>Therapeutic Area</h3><div>Ischemic Stroke</div></div><div><h3>Case Presentation</h3><div>A 67-year-old male, with paroxysmal atrial fibrillation (AF), CHADS-VASc 3, and HAS-BLED 3, was admitted for elective WATCHMAN left atrial appendage occlusion (LAAO). Following transesophageal echocardiography (TEE) measurements of the left atrial appendage (LAA), the 24-mm WATCHMAN FLX was selected given manufacturer recommendation of 10-27% compression rate. During the procedure, initial device deployment was successful with appropriate position, compression, and closure in setting of a prominent pectinate ridge. However, within minutes, blood pressure dropped, and electrocardiogram (ECG) showed nonsustained ventricular tachycardia and inferolateral ST elevations. Device compression was 18-23% and shoulder was 0-20%; there was no flow around the device. In the 90° TEE view, device edge to left circumflex (LCx) artery measured 2.4 mm. Upon device recapture, hemodynamic and ECG abnormalities resolved quickly. There was no evidence of air embolism or left atrial thrombus. Given mechanical compression of LCx by a properly sized and positioned device, a decision was made to discontinue the procedure. Postoperative ECG and imaging showed no acute changes. Patient remained asymptomatic and hemodynamically stable upon discharge.</div></div><div><h3>Background</h3><div>Reducing stroke risk is paramount in patients with AF, though chronic anticoagulation confers a major bleeding risk. Research has consistently highlighted the comparable efficacy of percutaneous LAAOs to oral anticoagulation in preventing stroke among nonvalvular AF patients. WATCHMAN LAAOs have increased in prevalence since its approval by the Food and Drug Administration in 2015. Despite their relative safety, a rare yet critical complication involves compression of the LCx coronary artery.</div></div><div><h3>Conclusions</h3><div>This represents the second reported case of LCx coronary artery compression by a WATCHMAN, resulting in hemodynamic instability and acute ST elevations that resolved with device removal. This complication warrants vigilance as recognition should lead to device withdrawal. Further investigation into patient specific risk factors is warranted to stratify risk prior to device implantation. Individual differences, such as preexisting coronary artery disease and proximity of left coronary artery and its branches to LAA should be considered. While current guidelines recommend sizing devices up for over-compression to minimize peri-device leaks, our case highlights that even within recommended compression ratios, mechanical coronary artery compression remains a risk.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667724001673","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Therapeutic Area

Ischemic Stroke

Case Presentation

A 67-year-old male, with paroxysmal atrial fibrillation (AF), CHADS-VASc 3, and HAS-BLED 3, was admitted for elective WATCHMAN left atrial appendage occlusion (LAAO). Following transesophageal echocardiography (TEE) measurements of the left atrial appendage (LAA), the 24-mm WATCHMAN FLX was selected given manufacturer recommendation of 10-27% compression rate. During the procedure, initial device deployment was successful with appropriate position, compression, and closure in setting of a prominent pectinate ridge. However, within minutes, blood pressure dropped, and electrocardiogram (ECG) showed nonsustained ventricular tachycardia and inferolateral ST elevations. Device compression was 18-23% and shoulder was 0-20%; there was no flow around the device. In the 90° TEE view, device edge to left circumflex (LCx) artery measured 2.4 mm. Upon device recapture, hemodynamic and ECG abnormalities resolved quickly. There was no evidence of air embolism or left atrial thrombus. Given mechanical compression of LCx by a properly sized and positioned device, a decision was made to discontinue the procedure. Postoperative ECG and imaging showed no acute changes. Patient remained asymptomatic and hemodynamically stable upon discharge.

Background

Reducing stroke risk is paramount in patients with AF, though chronic anticoagulation confers a major bleeding risk. Research has consistently highlighted the comparable efficacy of percutaneous LAAOs to oral anticoagulation in preventing stroke among nonvalvular AF patients. WATCHMAN LAAOs have increased in prevalence since its approval by the Food and Drug Administration in 2015. Despite their relative safety, a rare yet critical complication involves compression of the LCx coronary artery.

Conclusions

This represents the second reported case of LCx coronary artery compression by a WATCHMAN, resulting in hemodynamic instability and acute ST elevations that resolved with device removal. This complication warrants vigilance as recognition should lead to device withdrawal. Further investigation into patient specific risk factors is warranted to stratify risk prior to device implantation. Individual differences, such as preexisting coronary artery disease and proximity of left coronary artery and its branches to LAA should be considered. While current guidelines recommend sizing devices up for over-compression to minimize peri-device leaks, our case highlights that even within recommended compression ratios, mechanical coronary artery compression remains a risk.
左房阑尾闭塞术(LAO)期间继发于 Watchman 装置压迫左环(LCX)动脉的血压升高:病例报告
治疗领域缺血性卒中病例介绍一名 67 岁的男性患者患有阵发性心房颤动 (AF)、CHADS-VASc 3 和 HAS-BLED 3,入院接受 WATCHMAN 左心房阑尾封堵术 (LAAO) 治疗。在对左心房阑尾(LAA)进行经食道超声心动图(TEE)测量后,根据制造商的建议,选择了 24 毫米的 WATCHMAN FLX,压缩率为 10-27%。在手术过程中,最初的设备部署非常成功,位置适当,压迫到位,并在突出的栉状嵴处闭合。但在几分钟内,血压下降,心电图(ECG)显示非持续性室性心动过速和下外侧 ST 段抬高。装置压缩率为 18-23%,肩部为 0-20%;装置周围没有血流。在 90° TEE 视图中,装置边缘到左侧环状(LCx)动脉的距离为 2.4 毫米。重新取回装置后,血流动力学和心电图异常很快消失。没有发现空气栓塞或左心房血栓。鉴于尺寸和位置合适的装置对 LCx 造成了机械性压迫,因此决定终止手术。术后心电图和影像学检查未发现急性病变。背景降低房颤患者的中风风险至关重要,尽管长期抗凝会带来很大的出血风险。研究一直强调,在预防非瓣膜性房颤患者中风方面,经皮 LAAO 与口服抗凝药的疗效相当。WATCHMAN LAAO 自 2015 年获得美国食品和药物管理局批准以来,其普及率不断提高。尽管 WATCHMAN LAAOs 相对安全,但其罕见但严重的并发症是压迫 LCx 冠状动脉。结论这是第二例报道的 WATCHMAN LAAOs 压迫 LCx 冠状动脉的病例,导致血流动力学不稳定和急性 ST 升高,移除装置后症状缓解。这种并发症值得警惕,一旦发现应立即撤除装置。有必要进一步调查患者的特定风险因素,以便在植入装置前对风险进行分层。应考虑个体差异,如预先存在的冠状动脉疾病和左冠状动脉及其分支与 LAA 的邻近程度。虽然目前的指南建议对装置进行超压选型,以最大限度地减少装置周围渗漏,但我们的病例突出表明,即使在推荐的压缩比范围内,机械性冠状动脉压迫仍然存在风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信